SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13G - Statement of Beneficial Ownership by Certain Investors:
SEC Accession No. 0000921895-22-003095
Filing Date
2022-11-18
Accepted
2022-11-18 16:04:10
Documents
2

Document Format Files

Seq Description Document Type Size
1 sc13g13606cue_11182022.htm SC 13G 135703
2 ex991to13g13606cue_11182022.htm EX-99.1 9052
  Complete submission text file 0000921895-22-003095.txt   146291
Mailing Address 717 5TH AVENUE 16TH FL. NEW YORK NY 10022
Business Address 717 5TH AVENUE 16TH FL. NEW YORK NY 10022 212-257-4330
Slate Path Capital LP (Filed by) CIK: 0001559706 (see all company filings)

IRS No.: 800807580 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G

Mailing Address 40 GUEST STREET BOSTON MA 02135
Business Address 40 GUEST STREET BOSTON MA 02135 617-949-2680
Cue Biopharma, Inc. (Subject) CIK: 0001645460 (see all company filings)

IRS No.: 473324577 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G | Act: 34 | File No.: 005-90232 | Film No.: 221401937
SIC: 2834 Pharmaceutical Preparations